US drug companies announce vaccine initiativeBMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7237.736 (Published 18 March 2000) Cite this as: BMJ 2000;320:736
- James Ciment
- New York
Responding to an appeal from President Clinton, the heads of the world's four largest vaccine manufacturers announced a plan to donate $150m (£94m) worth of “state of the art” vaccines to the developing world after a meeting at the White House on 2 March.
The four companies—Merck and Company, American Home Products, SmithKline Beecham, and Aventis Pharmaceuticals—also pledged to increase their budgets for research and development for HIV/AIDS and malaria vaccines.
The donations will be channelled largely through the Global Alliance for Vaccines and Immunization, an international group of business leaders (including Bill Gates of Microsoft, philanthropic organisations, development banks, agencies …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial